Agenda
Current Paradigms in Cardiovascular Care of the Cancer Patient / Survivor
A Multidisciplinary Cardio-Oncology Symposium
| Time | Session / Description |
|---|---|
| 7:00–7:55 AM |
Registration & Breakfast
Check-in and light breakfast
|
| 7:25–7:55 AM |
1st Product Theatre
Industry-sponsored session (Alnylam Pharmaceuticals) Non-CE
|
| 7:55–8:00 AM |
Welcome & Introduction
Opening remarks, Dr. Tochukwu Okwuosa, Rush University Medical Center
|
| Session I: The Necessity for Cardio-Oncology | |
| 8:00–8:15 AM |
Where Heart Disease and Cancer Intersect, Cardiology Perspective
Dr. Clyde Yancy, Northwestern Medicine
|
| 8:15–8:30 AM |
Where Cancer and Heart Disease Intersect, Oncology Perspective
Dr. Susan Dent, University of Rochester
|
| 8:30–8:45 AM |
Cardio-Oncology: Forward and Reverse, An Overview
Dr. Anju Nohria, Brigham and Women’s Hospital
|
| 8:45–9:05 AM |
Panel Discussion, Interactive Q&A
Moderator: Dr. Sunil Pauwaa, Advocate Health
|
| 9:05–9:15 AM | Short Break |
| Session II: Cardiovascular Risks of Oncological Therapies | |
| 9:15–9:30 AM |
Culprit Chemotherapies and Cardiotoxicity: Anthracyclines and Beyond
Dr. Salaheldin Abusin, Rush University Medical Center
|
| 9:30–9:45 AM |
Radiation-Associated Cardiotoxicity: Past, Present, and Future
Dr. Thomas Kim, Rush University Medical Center
|
| 9:45–10:00 AM |
Targeted Therapies for Cancer Treatment: The Heart as a Target?
Dr. Daniel Addison, UT Southwestern Medical Center
|
| 10:00–10:10 AM | Short Break |
| 10:10–10:25 AM |
Stem Cell Transplant and CAR-T Cell Therapy
Dr. Michael Fradley, Penn Medicine
|
| 10:25–10:40 AM |
Endocrine and Hormone Therapies: The Forgotten Long-Term Cancer Therapies
Dr. Charles Porter, University of Kansas Medical Center
|
| 10:40–11:00 AM |
Panel Discussion, Interactive Q&A
Moderator: Dr. Lynne Braun, Rush University Medical Center
|
| Session III: Risk Assessment in Cardio-Oncology | |
| 11:00–11:15 AM |
Biomarkers in Risk Assessment
Dr. Marianna Krive, Advocate Health
|
| 11:15–11:30 AM |
Imaging for Risk: Beyond MUGA and 2D Echo
Dr. Jeanne DeCara, University of Chicago Medicine
|
| 11:30 AM–12:45 PM |
Poster Presentations & Lunch
Fitzgerald Salon, networking + CME credit. Research, abstracts, and case reports posters are non-CME accredited.
|
| 11:50–12:05 PM |
Immune Checkpoint Inhibitors and the Heart, Non-CME Session
Dr. Aarti Asnani, Beth Israel Deaconess Medical Center and Harvard Medicine
|
| 12:05–12:35 PM |
2nd Product Theatre
Industry-sponsored session, Pfizer Rare Cardiac Non-CE
|
| 12:45–1:00 PM |
Traditional Cardiovascular Risk Factors for Risk Assessment in Cardio-Oncology
Dr. Menhel Kinno, Rush University Medical Center
|
| 1:00–1:15 PM |
Risk Assessment Prior to Stem Cell Transplant and CAR-T Therapy
Dr. Avirup Guha, Medical College of Georgia
|
| 1:15–1:30 PM |
Case Presentation: Cardio-Oncology Risk Tools in Use
Dr. Anjali Rao, Northwestern Medicine
|
| 1:30–1:50 PM |
Panel Discussion
Moderator: Dr. Sandra Naaman, Rush University Medical Center
|
| 1:50–2:00 PM | Short Break |
| Session IV: Management Considerations & Future Directions | |
| 2:00–2:15 PM |
Medical Therapy & Anticoagulation During Cancer Treatment
Dr. Nausheen Akhter, Northwestern Medicine
|
| 2:15–2:30 PM |
Cancer Survivorship: Definitions and Management
Dr. Dennis Yu, Loyola University Medical Center
|
| 2:30–2:45 PM |
Big Data, Registries, and Precision Cardio-Oncology
Dr. Diego Sadler, Cleveland Clinic
|
| 2:45–3:00 PM |
Panel Discussion
Dr. Mary Rodriguez Ziccardi, University of Illinois Hospital & Health Sciences System
|
| 3:00–3:10 PM |
Guest Speaker
Dr. Rupa Sanghani, Rush University Medical Center
|
| 3:10 PM onward |
Reception & Poster Awards
Drinks, hors d’oeuvres, networking, and closing remarks, Dr. Tochukwu Okwuosa, Rush University Medical Center
|